2026 MIPS Measure #386: Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences
Quality ID386
eMeasure IDNone
NQFNone
High-Priority MeasureYes
Specifications
—
Measure TypeProcess
MVP IDYes (MVP ID: M0004)
Specialty
Neurology
Speech Language Pathology
Measure Description
Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, lawful physician-hastened death, or hospice) or whose existing end of life plan was reviewed or updated at least once annually or more frequently as clinically indicated (i.e., rapid progression).
Measure Submission Type
MIPS clinical quality measures (MIPS CQMs)